An International MDS/MPN Working Group's perspective and recommendations on molecular pathogenesis, diagnosis and clinical characterization of myelodysplastic/myeloproliferative neoplasms.
about
Therapeutic approaches in myelofibrosis and myelodysplastic/myeloproliferative overlap syndromesHow we manage immune thrombocytopenia in the elderly.GEP analysis validates high risk MDS and acute myeloid leukemia post MDS mice models and highlights novel dysregulated pathways.Routine clinical mutation profiling using next generation sequencing and a customized gene panel improves diagnostic precision in myeloid neoplasms.Clinical management of myelodysplastic syndrome/myeloproliferative neoplasm overlap syndromes.Routine blood examinations combined with morphological analysis for the diagnosis of myelodysplastic/myeloproliferative neoplasms.Allogeneic hematopoietic stem cell transplantation for myelofibrosis and chronic myelomonocytic leukemia.Turning the tide in myelodysplastic/myeloproliferative neoplasms.An international consortium proposal of uniform response criteria for myelodysplastic/myeloproliferative neoplasms (MDS/MPN) in adults.Oligomonocytic chronic myelomonocytic leukemia (chronic myelomonocytic leukemia without absolute monocytosis) displays a similar clinicopathologic and mutational profile to classical chronic myelomonocytic leukemia.Integrating clinical features and genetic lesions in the risk assessment of patients with chronic myelomonocytic leukemia.FGFR1OP2-FGFR1 induced myeloid leukemia and T-cell lymphoma in a mouse model.Bone marrow fibrosis in chronic myelomonocytic leukemia is associated with increased megakaryopoiesis, splenomegaly and with a shorter median time to disease progression.Emerging mechanisms of long noncoding RNA function during normal and malignant hematopoiesis.Atypical chronic myeloid leukemia: a rare entity with management challenges.Targeted next-generation sequencing using a multigene panel in myeloid neoplasms: Implementation in clinical diagnostics.A phase II trial of ruxolitinib in combination with azacytidine in myelodysplastic syndrome/myeloproliferative neoplasms.Myelodysplastic/myeloproliferative neoplasms: a disease in need of recognition.The myeloproliferative neoplasms, unclassifiable: clinical and pathological considerations.The JAK2 V617F mutation in patients with anaemia.The mutational landscape of 18 investigated genes clearly separates four subtypes of myelodysplastic/myeloproliferative neoplasms.SRSF2 mutations in myelodysplasia/myeloproliferative neoplasms
P2860
Q26752940-1A4E272A-BBFD-43D2-9A36-39D0BE409654Q33431371-A4C966D9-3CE3-4741-A83F-24CD1A9203F8Q36507980-AAB7A544-06CE-4D84-8757-4367D8A9DD9BQ37327426-2FF5140C-D0D1-4247-84EC-C53FCC32E93EQ37349392-D407B423-5767-4675-A717-14594852C9D8Q37407367-6548C80D-2D55-4B96-A45B-EE6E91BC2B93Q38603384-8BA121EA-3468-4CA6-8CAA-C3685AC0C843Q38712988-6CCDD378-C4DE-4867-8E71-7F3800F19F39Q39048645-D3E5E027-B9D7-49F8-8288-A5B51382FD58Q40184243-F3BF03A6-1A7A-4664-9ACD-A578B723232AQ41183059-C4AF661A-FAB2-4A22-AC5D-732AB93C97C4Q42923858-E0961D0E-140E-4946-A61E-551CE960B12EQ47094379-2E1F4D7E-FA5E-4CE1-ACFA-E0DFD7188C00Q47657395-81C4280D-031E-47F8-9E84-DBB596D1B362Q47789741-9F351C09-187A-4BE8-BFCE-3E4E6A17A06FQ48102067-ECCB695C-E9A1-4B14-B763-9A09972F35CBQ48309941-87CB67B6-BB11-4BBA-80A0-4BCC6F11316DQ50891297-CEC656B8-944F-4B5B-B712-2985923393BAQ52844230-406782A1-053C-4EE1-8C8B-670D3C246D2FQ53808255-8A054713-0392-4EDD-9D30-B16E785432C4Q55324702-B12DE72A-2FE5-4072-8FF4-308C8F025CE4Q57069030-3C914BE6-9094-4D20-8EC6-2BCC42E79D1D
P2860
An International MDS/MPN Working Group's perspective and recommendations on molecular pathogenesis, diagnosis and clinical characterization of myelodysplastic/myeloproliferative neoplasms.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
An International MDS/MPN Worki ...... /myeloproliferative neoplasms.
@ast
An International MDS/MPN Worki ...... /myeloproliferative neoplasms.
@en
type
label
An International MDS/MPN Worki ...... /myeloproliferative neoplasms.
@ast
An International MDS/MPN Worki ...... /myeloproliferative neoplasms.
@en
prefLabel
An International MDS/MPN Worki ...... /myeloproliferative neoplasms.
@ast
An International MDS/MPN Worki ...... /myeloproliferative neoplasms.
@en
P2093
P2860
P50
P1433
P1476
An International MDS/MPN Worki ...... c/myeloproliferative neoplasms
@en
P2093
Attilio Orazi
Eric Padron
Ghulam Mufti
Guillermo Garcia-Manero
Jaroslaw P Maciejewski
Luca Malcovati
Pierre Fenaux
Rami S Komrokji
Ramon V Tiu
Raoul Tibes
P2860
P304
P356
10.3324/HAEMATOL.2014.114660
P50
P577
2015-09-01T00:00:00Z